XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses:    
Research and development $ 155,040 $ 120,257
General and administrative 59,946 47,075
Total operating expenses 214,986 167,332
Loss from operations (214,986) (167,332)
Other income:    
Other income, net 957 271
Total other income 957 271
Net loss $ (214,029) $ (167,061)
Net loss per share attributable to common stockholders, basic (in usd per share) $ (4.64) $ (3.94)
Net loss per share attributable to common stockholders, diluted (in usd per share) $ (4.64) $ (3.94)
Weighted average common shares outstanding, basic (in shares) 46,096,737 42,454,055
Weighted average common shares outstanding, diluted (in shares) 46,096,737 42,454,055